clinical outcomes of immunotherapy after radiographic progression in advanced nsclc
Published 2 years ago • 166 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
1:12
the role of gut microbiome on immunotherapy outcomes in lung cancer
-
1:24
transforming outcomes in advanced lung cancer: immunotherapy in unselected patients
-
1:33
continuing io in geriatric patients with nsclc with radiographic progression
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
44:56
advanced nsclc: refining clinical pathways in the rapidly evolving therapeutic landscape
-
53:49
the role of immunotherapy in late stage nsclc webinar
-
2:48
jvdf: immune profiling and clinical outcomes in patients treated with ramucirumab and pembrolizumab
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
7:13
nsclc: immunotherapy beyond progression
-
8:13
asco 2021 lung recap: fda analysis of immunotherapy with or without chemo in adv nsclc and low pdl-1
-
0:47
the role of immunotherapy with kras inhibitors in kras-driven nsclc
-
1:00:44
practical application of recent clinical data for immunotherapy in nsclc
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
7:40
can immunotherapy play a role in locally advanced nsclc?
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
1:51
outcomes of i-sabr in lung cancer
-
10:20
imaging 101: immunotherapy criteria
-
0:32
improving patient-reported outcomes in nsclc